Product Details
| Product Name: Artemisinin | CAS No.: 63968-64-9 |
| Min. Order: 5mg | Purity: ≥98%(HPLC) |
| Supply Ability: 10 g | Release date: 2023/02/24 |
Product Name: Artemisinin ( Reference Standard )
Molecular Formula: C15H22O5
Molecular Weight: 282.33
Plant Source : Artemisia apiacea
Type of Compound: Sesquiterpenoids
Testing Method: HPLC
Identification Method: MS, NMR
Packing: As per customer's requirement
Usage/Application : Identification purpose
Storage: Store in a closed container for protection from air and light. Refrigerated or frozen for a long time.
Provide COA ,MSDS and Test Report
Company Profile Introduction
NatureStandard was founded with a mission to facilitate pharmaceutical research by providing high quality Reference Standards,Analytical Standards and related technical services including separation and manufacturing of components from Traditional Chinese Medicine (TCM) ,development of extraction technology , technical outsourcing service for Registration and Application of TCM (Plant Medicine) .Our products/services are quality-certified and delivered with care and pride from our home in Shanghai to clients worldwide.
You may like
-
CAS:191729-45-0
-
CAS:18642-23-4
-
CAS:484-20-8
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $64.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-26 | |
| $64.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-26 | |
| $64.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-26 | |
| $1200.00 |
VIP1Y
|
Lianyungang Kaiyu Environmental Tech Co., Ltd.
|
2025-09-30 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-08 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-27 | ||
|
VIP3Y
|
BINBO BIOLOGICAL CO.,LTD
|
2025-03-25 | ||
| $139.00 |
VIP2Y
|
HANGZHOU HAILAN CHEMICAL CO.,LTD.
|
2025-03-18 | |
| $30.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-24 |
China- Since: 2019-07-10
- Address: Room 206C, Building 2, 720 Cailun Road ,Shanghai 201203, China.
INQUIRY